31.05.2016 MediClin AG  DE0006595101

DGAP-News: MediClin takes legal actions regarding reclaim of overcharged lease payments


 
DGAP-News: MediClin AG / Key word(s): Miscellaneous MediClin takes legal actions regarding reclaim of overcharged lease payments 31.05.2016 / 14:08 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MediClin takes legal actions regarding reclaim of overcharged lease payments Offenburg, 31 May, 2016 - Today MEDICLIN Aktiengesellschaft (MediClin) filed a lawsuit in the district court Offenburg, to put forwards claims regarding repayment of above market-based paid rents. For the period of 2005 to 2015 the Company assumes that the paid rent in total was above the market-based rate. The lawsuit is directed against existing and former shareholders of the Company, who are shareholders of the real estate fund, in which the acquired and leased-back clinics were pooled between 1999 and 2001. Considered the chances and risks of the lawsuit, MediClin has taken into account that subject of this lawsuit will be − especially the evaluation of the customariness of the respective rent − a complex issue and difficult legal aspects partly judicially by the Supreme Court not yet answered. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post- acute treatment and medical rehabilitation. MediClin has approximately 9,000 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------------- 31.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-326 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 467965 31.05.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,740 Halten 130,15
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,54 19,26 0,57 20,60
KBV KCV KUV EV/EBITDA
0,66 1,67 0,18 1,52
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
6,24% 0,66% 0,00% -11,04%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED